​​​​​​​US peace plan to include Jerusalem as Palestinian capital concerns Israel

US peace plan to include Jerusalem as Palestinian capital concerns Israel

Agencies

October 22, 2018

Jerusalem,Oct 22: Israel is reportedly concerned that the Trump administration is considering recognizing Jerusalem as the Palestinian as well as the Israeli capital in a bid to bring Palestinian Authority President Mahmoud Abbas back to the negotiating table.

A senior Israeli official said “Trump wants a deal and he’s very serious.”
“To the Americans, the Israeli-Palestinian conflict is relatively easy to solve", reports the Yedioth Ahronoth daily.

Sources told the newspaper that US-led talks between the two sides will work on a strategy of give and take: Anyone who comes to the table has to ante up a concession, one the other side agrees to.

Anyone who doesn’t come to the table has to pay a penalty, and anyone who rejects the draft deal risks being put in a weaker position for the next round.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments